| Literature DB >> 36185857 |
Pratyaksh Chhabra1, Nishikant Ingole2.
Abstract
Millions of people worldwide are affected by the prevalent clinical issue, gastroesophageal reflux disease (GERD). Both conventional and unusual symptoms can identify patients. Many people with GERD benefit from symptomatic relief and are shielded from consequences by acid suppression medication. Our capacity to recognise and manage disease consequences has improved thanks to developments in diagnostic and therapeutic technologies. One of the biggest typical gastrointestinal problems treated by physicians and primary care doctors is GERD, which is characterised by heartburn and regurgitation symptoms. GERD prevalence has increased, especially in North America and East Asia. Proton pump inhibitors (PPIs) have been the cornerstone of medical treatment for GERD for the past thirty years. However, clinicians and patients are becoming more aware of the adverse effects of the PPI class of medications recently. Additionally, surgical fundoplication has significantly decreased, while the evolution of non-medical therapeutic methodologies for GERD has increased. In the treatment of GERD, lifestyle changes are crucial. Individual variances can be seen in how GERD symptoms change in response to different diets. The study implies that there may be a connection between reflux occurrence and salty foods, chocolates, fat-rich foods, and aerated beverages, even if there is insufficient data to support this theory. In lifestyle modifications, other factors involved are the head of the bed, patients' lying down position, smoking, fat or obesity, and physical exercise. The number of reviews focusing on various diagnostic techniques and treatment modalities is very less, so this review puts emphasis on these areas. This review also covers GERD and its symptoms, epidemiology, and pathophysiology, but significantly focuses on diagnosis, treatment, and lifestyle modification effects.Entities:
Keywords: diagnosis; gastroesophageal reflux disease; gerd; lifestyle; treatment
Year: 2022 PMID: 36185857 PMCID: PMC9517688 DOI: 10.7759/cureus.28563
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1The complex pathogenesis of GERD
EGJ = esophagogastric junction; LES = lower esophageal sphincter
Image source: Savarino et al., 2021 [7] (Open access)
Manifestations of GERD
Table source: Henry, 2014 [14] (Open access)
| Typical manifestations | Atypical manifestations | ||
| Pulmonary | Otorhinolaryngological | Oral | |
| Dyspepsia, Regurgitation of acid | Wheezing (chronic), Inflammation of the pharynx, Throat clearing, Pneumonia, Bronchiectasis, Asthma | Sore throat, Otitis, Inflammation of sinuses | Tooth erosion, Halitosis, Aphtha |
Los Angeles endoscopic classification
Table source: Henry, 2014 [14] (Open access)
| Grade of Reflux Esophagitis | Discovery |
| A | Single or more erosions minor than 5 mm |
| B | Single or more erosions bigger than 5 mm in its larger addition, discontinued within esophageal fold apices |
| C | Contiguous erosions within at least esophageal fold apices, commitment of less than 75% of the esophagus |
| D | Erosion of minimum 75% of the esophagus circumference |
Behavioural measures for GERD-affected individuals below 40 years of age
Table source: Henry, 2014 [14] (Open access)
|
| Behaviour |
| 1 | Bed head elevation |
| 2 | Restraint in the consumption of such foods: eatables which are fatty, citric fruits, caffeine, alcoholic beverages and/or aerated drinks, mints, peppermints, tomato, chocolates |
| 3 | Particular precaution with high-risk medicines: anticholinergics, theophylline, calcium-channel blockers, alendronate |
| 4 | Restraint from reclining in the two hours after eating meals |
| 5 | Restraint from bigger meals |
| 6 | Quitting smoking |
| 7 | Body weight reduction |
Figure 2Brandalise and Aranha's fundoplication procedure
Image source: Brandalise et al., 1996 [14] (Open access)